Li Y
Impact in
- Cancer Research top 2%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Oncology top 10%
- Lung Cancer Research Studies
- Cancer Immunotherapy and Biomarkers
Papers in
-
- Cancer-related molecular mechanisms research 33
- MicroRNA in disease regulation 27
- Oncology 33
- Lung Cancer Research Studies 16
- Cancer Immunotherapy and Biomarkers 9
- Co-authors
- Jun Chen (44 shared papers)Hongyu Liu (26 shared papers)Ying Li (15 shared papers)Hongbing Zhang (22 shared papers)Qinghua Zhou (5 shared papers)Ruifeng Shi (20 shared papers)Zihe Zhang (16 shared papers)Hongyu Liu (16 shared papers)
- Journals
- Journal of Cancer (6 papers)Frontiers in Immunology (5 papers)Acta Pharmacologica Sinica (4 papers)Frontiers in Oncology (3 papers)OncoTargets and Therapy (3 papers)
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Li Y
235 papers receiving 2.7k citations
Peers
Comparison fields: 5 of 102
- Cancer Research 888
- Oncology 312
- Molecular Biology 658
- Pulmonary and Respiratory Medicine 309
- Hepatology 80
Countries citing papers authored by Li Y
This map shows the geographic impact of Li Y's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li Y with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li Y more than expected).
Fields of papers citing papers by Li Y
This network shows the impact of papers produced by Li Y. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li Y. The network helps show where Li Y may publish in the future.
Co-authors
The 25 scholars most cited alongside Li Y, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 255 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 105 | |
| 2 | 2013 | 102 | |
| 3 | Allelotyping of all chromosomal arms in invasive cervical cancer. | 1996 | 80 |
| 4 | 2012 | 80 | |
| 5 | MALAT1 is an oncogenic long non-coding RNA associated with tumor invasion in non-small cell lung cancer regulated by DNA methylation. | 2015 | 77 |
| 6 | 2018 | 70 | |
| 7 | 2017 | 68 | |
| 8 | 2021 | 65 | |
| 9 | 2017 | 60 | |
| 10 | Long non-coding RNA CCAT2 promotes the breast cancer growth and metastasis by regulating TGF-β signaling pathway. | 2017 | 57 |
| 11 | 2018 | 56 | |
| 12 | 2015 | 52 | |
| 13 | 2021 | 49 | |
| 14 | 2011 | 48 | |
| 15 | 1994 | 47 | |
| 16 | MicroRNA-7 inhibits metastasis and invasion through targeting focal adhesion kinase in cervical cancer. | 2015 | 45 |
| 17 | 2020 | 38 | |
| 18 | 2017 | 36 | |
| 19 | 2013 | 35 | |
| 20 | 2016 | 35 |
About Li Y
Li Y is a scholar working on Cancer Research, Oncology, Molecular Biology, Pulmonary and Respiratory Medicine and Biotechnology, having authored 255 papers that have together received 2.7k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (33 papers), MicroRNA in disease regulation (27 papers), Lung Cancer Treatments and Mutations (18 papers), Lung Cancer Research Studies (16 papers), Cancer Immunotherapy and Biomarkers (9 papers), Epigenetics and DNA Methylation (9 papers), Circular RNAs in diseases (8 papers) and Tuberculosis Research and Epidemiology (6 papers). The work is most often cited by research in Cancer Research (888 citations), Oncology (312 citations), Molecular Biology (658 citations), Pulmonary and Respiratory Medicine (309 citations) and Hepatology (80 citations). Li Y has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Jun Chen, Hongyu Liu, Ying Li, Hongbing Zhang, Qinghua Zhou, Ruifeng Shi, Zihe Zhang, Hongyu Liu, Fengjie Guo and Yaguang Fan. Their work appears in journals such as Journal of Cancer, Frontiers in Immunology, Acta Pharmacologica Sinica, Frontiers in Oncology and OncoTargets and Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.